AthleticsRuti Aga's Six-Year Ban: A Knee Injection, a Forged Prescription, and the End of a Career
Athletics

Ruti Aga's Six-Year Ban: A Knee Injection, a Forged Prescription, and the End of a Career

**मुख्य उत्तर** इथियोपियाई मैराथन धावक रुति अगा पर एथलेटिक्स इंटीग्रिटी यूनिट (AIU) ने छह साल का प्रतिबंध लगाया — दो साल मेथिलप्रेडनिसोलोन के शरीर में मिलने पर और चार साल नकली प्रिस्क्रिप्शन देकर जाँच से छेड़छाड़ पर। प्रतिबंध 10 सितंबर से गिना जाता है, जब उनका अनंतिम निलंबन शुरू हुआ था। **मुख्य तथ्य** - मेथिलप्रेडनिसोलोन WADA सूची की S9 श्रेणी में ग्लूकोकोर्टिकॉइड है, एनाबॉलिक स्टेरॉयड नहीं; यह केवल इन-कॉम्पिटिशन और केवल इंजेक्शन, मुँह या रेक्टल मार्ग से प्रतिबंधित है। - पॉज़िटिव नमूना मार्च में चीन की एक हाफ मैराथन जीतने के बाद लिया गया; उस रेस का समय स्रोत में दर्ज नहीं है। - AIU के अनुसार पर्ची परिवार के एक अपंजीकृत सदस्य ने लिखी; पर्ची पर नामित क्लिनिक अस्तित्व में नहीं था। - रुति अगा 2019 टोक्यो मैराथन की विजेता हैं और वर्ल्ड मैराथन मेजर्स में तीन बार दूसरे स्थान पर रही हैं। - 32 वर्षीय अगा की संभावित वापसी 38 की उम्र में होगी; मार्च रेस के नतीजे और इनामी रकम का रद्द होना मानक AIU प्रक्रिया के तहत अपेक्षित है। **स्रोत** एथलेटिक्स इंटीग्रिटी यूनिट (AIU) का बयान, जिसका हवाला मूल रिपोर्ट में दिया गया है; WADA प्रतिबंधित सूची (2021), श्रेणी S9। बयान गुरुवार को जारी हुआ; प्रतिबंध की तारीख 10 सितंबर है, वर्ष का स्पष्ट उल्लेख स्रोत में नहीं है। **संबंधित प्रश्न-उत्तर** प्रश्न: रुति अगा पर छह साल का प्रतिबंध क्यों लगा? उत्तर: दो साल शरीर में प्रतिबंधित पदार्थ मिलने पर और चार साल नकली प्रिस्क्रिप्शन देकर जाँच से छेड़छाड़ करने पर, जिसकी गिनती 10 सितंबर से होती है। प्रश्न: क्या उनका 2019 टोक्यो मैराथन खिताब रद्द होगा? उत्तर: स्रोत में रद्दीकरण का दायरा नहीं बताया गया; पहले के किसी उल्लंघन का निष्कर्ष न होने पर 2019 का खिताब अपने आप रद्द नहीं होता। प्रश्न: घुटने का थेरेप्यूटिक इंजेक्शन कब वैध रहता है? उत्तर: S9 ग्लूकोकोर्टिकॉइड प्रतियोगिता से बाहर वैध है, पर प्रतियोगिता के दिन शरीर में इसकी मौजूदगी उल्लंघन बन जाती है, इसलिए रूट और वॉशआउट अवधि का हिसाब ज़रूरी है।

In March, at a half marathon in China, a name was read out at the finish line — Ruti Aga. The report that carried this story gives no time, no split, no field strength for that race. Only this: the race was won, and the sample collected afterwards came back positive.

In 2026, aged sixteen, I was the PA announcer at the Telangana State Junior Athletics Meet in Hyderabad. In the boys' 100m final I mispronounced the winner's name three times, turning M. Srinivas into "Srinivasa" and "Srinivason". He had run 10.9 seconds on a dirt track and trained barefoot after school. I learned to pronounce my own name by hearing strangers get it wrong. Since then I have a small habit: in any results list I look at the name first, the number second.

Ruti Aga's Six-Year Ban: A Knee Injection, a Forged Prescription, and the End of a Career

Now that name is in a statement. On Thursday the Athletics Integrity Unit (AIU) announced a six-year ban — two years for the presence of a prohibited substance, four for tampering. The clock starts on 10 September, the date her provisional suspension began.

Ruti Aga is a 32-year-old Ethiopian marathoner, part of the generation that normalised the 2:18-2:20 range in 2026-19. Her personal best is not given in the source; public records place her at 2:18:34 for second in Berlin 2026 and 2:20:40 for the win in Tokyo 2026, though those figures remain pending independent verification. What the source does confirm: she won the 2026 Tokyo Marathon and finished second at three World Marathon Majors.

Then the March half marathon in China. Then the investigation. Her explanation was straightforward: a knee injury, treated with a methylprednisolone injection. The question turned out to be about paper, not medicine. According to the AIU, the prescription was written by a family member with no medical registration, who claimed to have used an old prescription pad from a former workplace. The clinic named on the slip did not exist, or disowned the pad outright. Three separate verification failures, on a single sheet.

The drug class, and the mistake every report is repeating

Start with the technical point that is the legal spine of this case and that the coverage got wrong. Methylprednisolone is not an anabolic steroid. It is a glucocorticoid, class S9 on the WADA Prohibited List. And S9 is conditional twice over: prohibited in-competition only, and only by injection, oral or rectal routes. The same therapeutic knee injection that is entirely legal out of competition becomes a violation if residues are still present on race day.

That distinction is what makes the case reversible in principle. With genuine medical records, the defence had a clean path — route, date, dose, and days before competition. In road racing the testing window opens at 23:59 the day before the race, so an injection given days earlier can still be caught. The entire case rested on who kept track of route and timing. Instead of answering that question, a prescription was manufactured.

Four of the six years are about paper

Read the arithmetic. Two years for presence, four for tampering. Four years is the Code's standard tampering sanction. The two-year presence term is consistent with a specified substance finding where intent was not proven. The sum also tells us the panel rejected the no-significant-fault mitigation that would have trimmed the presence sanction. In other words, what ended the career was less the injection than the document describing it.

Three verifications, three failures: the clinic on the slip did not exist; the prescriber was not registered; the old pad was disowned by the institution it was attributed to. That is why the four years rest on a document rather than testimony, and why it will be hard to overturn.

The structure that was missing

The loudest thing in this case is what is never mentioned: there is no sign of a TUE process anywhere. A marathoner with chronic knee pathology has two routes — a Therapeutic Use Exemption backed by records, or a strict accounting of route-specific washout. Neither happened; a prescription was produced instead. The failure sits in entourage governance, not in filing.

The economics sharpen it. For a 2:18-2:20 Ethiopian, the Asian label-race circuit between Majors is the main income line — few races, high appearance fees. That same tier is now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding in the same races, and the athlete stands alone at the point of collision.

The career math is blunt. Age 32, six years out — a return at roughly 38. Against Ethiopia's women's marathon depth, a 38-year-old with a doping record is effectively unselectable. The March result and its prize money should be treated as annulled under standard AIU practice, though the statement does not spell it out. What does not disappear: the 2026 Tokyo title and three Major runner-up finishes. Absent a finding of earlier use, results before the violation date are not automatically voided.

The easy reading is that another East African runner was caught. I think that reading is wrong, and not only because it is unkind.

First, there is no solid evidence that glucocorticoids improve endurance performance. The substance that drew a six-year ban does not answer the question anti-doping systems actually ask: did the result change? The weight of this sanction sits on the cover-up. Reading it purely as a doping story lets us skip the part that is repeatable — the knee, the absence of treatment, the relative who wrote the slip.

Second, the coverage called it a steroid. That is not a small error. If the next runner with a sore knee grows up reading that legitimate treatment becomes a steroid headline, she will hide the treatment — and hiding it is exactly what turned into four years here. Language is part of justice.

Ruti Aga's Six-Year Ban: A Knee Injection, a Forged Prescription, and the End of a Career

Third, the invisible party is the structure around the athlete, not the athlete. The AIU named one family member. No agent, no manager, no training-group doctor. Who accepted that slip, who said it would pass — those questions remain open, and while they do, the next injured runner has the same path available.

In 2026, calling a Gold Coast race from a bedroom, I felt the discus circle meet the javelin runway — two memories talking to each other. Here the motion is reversed: a result is about to be erased from memory, and the clinic that signed the paper never existed.

Three things to watch. Whether the AIU confirms the annulment of the March result and prize money. Whether anyone in the entourage is charged. Whether there is a CAS appeal, with a window that typically stays open about 21 days from the reasoned decision.

And one question no sanction touches. The empty stadium in Patiala taught me that silence can have a chorus. In this case the silence is in the medical room, behind a document someone accepted without asking. Who treats the next 2:18 runner's knee, and whether she has a real prescription, will decide whether these six years were a lesson or just a number.

संबंधित खिलाड़ी